BlackRock

BlackRock

贝莱德 的页面基于SEC 13F 文件汇总公开披露的持仓变化、调仓方向和相关股票。 贝莱德 的记录会保留披露来源、报告期和可核查证据,方便把 13F 数据放在延迟披露的语境中阅读。 当前快照更新到2024年8月13日,主要包含增持动向、减持动向、and exits,相关股票包括NVIDIA Corporation (NVDA)、Apple Inc (AAPL)、Microsoft Corp (MSFT)、Alphabet Inc (GOOGL)。披露金额以 $227.5B to $247.7B 区间展示。 13F 是季度且延迟的公开披露,不代表实时持仓,也不构成投资建议。

数据来源与方法论

最新持仓

持仓Reported ValueWeightSharesLast PriceEst. ValueReturn
9770210497702104 · Q2 2024$200k0.0%267k------
SurgePays, Inc.SURG · Q2 2024$199k0.0%62k$0.5702----
G5391L110G5391L110 · Q2 2024$198k0.0%495k------
62526P40662526P406 · Q2 2024$197k0.0%82k------
Crexendo, Inc.CXDO · Q2 2024$196k0.0%62k$7.69----
08205P20908205P209 · Q2 2024$196k0.0%28k------
First National CorporationFXNC · Q2 2024$195k0.0%13k$28.04----
First Guaranty Bancshares, Inc.FGBI · Q2 2024$195k0.0%22k$10.09----
Lisata Therapeutics, Inc.LSTA · Q2 2024$194k0.0%56k$3.30----
Camtek Ltd.CAMT · Q2 2024$193k0.0%1.5k$169.62----
140755109140755109 · Q2 2024$192k0.0%745k------
a.k.a. Brands Holding Corp.AKA · Q2 2024$190k0.0%12k$9.36----
Pioneer Power Solutions, Inc.PPSI · Q2 2024$189k0.0%48k$5.49----
Adaptimmune Therapeutics plcADAPY · Q2 2024$189k0.0%194k$0.0087----
34960Q30734960Q307 · Q2 2024$188k0.0%110k------
46434V10046434V100 · Q2 2024$186k0.0%3.8k------
Lantern Pharma Inc.LTRN · Q2 2024$186k0.0%40k$3.50----
2311120623111206 · Q2 2024$186k0.0%270k------
744413105744413105 · Q2 2024$185k0.0%411k------
67079U20767079U207 · Q2 2024$183k0.0%307k------
12520L10912520L109 · Q2 2024$182k0.0%9.7k------
Westwater Resources, Inc.WWR · Q2 2024$180k0.0%374k$0.5726----
4648430946484309 · Q2 2024$180k0.0%20k------
464287549464287549 · Q2 2024$178k0.0%1.9k------
1.3811E+1051.3811E+105 · Q2 2024$177k0.0%8.1k------
26145B10626145B106 · Q2 2024$175k0.0%207k------
Perma-Pipe International Holdings, Inc.PPIH · Q2 2024$175k0.0%20k$32.19----
Invesco Russell 1000 Dynamic Multifactor ETFOMFL · Q2 2024$175k0.0%3.3k$68.47----
Key Tronic CorporationKTCC · Q2 2024$175k0.0%43k$3.30----
Streamline Health Solutions, Inc.STRM · Q2 2024$174k0.0%378k$5.33----
82933R30882933R308 · Q2 2024$173k0.0%20k------
744375205744375205 · Q2 2024$172k0.0%71k------
19188J40919188J409 · Q2 2024$172k0.0%74k------
185064102185064102 · Q2 2024$172k0.0%206k------
QXO, Inc.QXO · Q2 2024$172k0.0%2.4k$17.40----
Cumberland Pharmaceuticals Inc.CPIX · Q2 2024$169k0.0%111k$5.98----
The Dixie Group, Inc.DXYN · Q2 2024$168k0.0%256k$0.35----
TriSalus Life Sciences, Inc.TLSI · Q2 2024$167k0.0%30k$3.27----
497498105497498105 · Q2 2024$164k0.0%101k------
46429B40846429B408 · Q2 2024$164k0.0%6.8k------
67577R10267577R102 · Q2 2024$164k0.0%107k------
59134N30259134N302 · Q2 2024$163k0.0%54k------
00973N10200973N102 · Q2 2024$163k0.0%1.2M------
New Gold IncNGD · Q2 2024$161k0.0%83k$9.08----
Usio, Inc.USIO · Q2 2024$161k0.0%105k$1.98----
Barnwell Industries, Inc.BRN · Q2 2024$160k0.0%68k$1.05----
207523101207523101 · Q2 2024$158k0.0%104k------
Trajectory Alpha Acquisition Corp.TCOA · Q2 2024$156k0.0%14k$10.51----
98973P20098973P200 · Q2 2024$155k0.0%222k------
88165K10188165K101 · Q2 2024$154k0.0%213k------
Showing 4501-4550 of 5227